Poland Mirosław Wysocki, national consultant in the area of Public Health, professor at the National Institute of Public Health (NIH), the research institute responsible inter alia for health promotion and disease prevention, discusses the overwhelming challenge of shifting the nation’s healthcare mentality from a curative approach, to a prevention lifestyle system.…
Canada Eric Tse, general manager of Shire Canada, highlights the affiliate’s exciting journey over the past four years, including new office location in downtown Toronto, and the launch of six new products in 2017 alone; Shire’s portfolio of innovative solutions across rare diseases and other areas like attention-deficit/hyperactivity disorder (ADHD); and…
Switzerland Petra Exner and Tobias Haber discuss the unique service offering of INSIGHT Health, one of the leading data providers to the healthcare market, the company’s successful internationalization strategy, and why INSIGHT Health is the partner of choice. Could you begin by introducing INSIGHT Health to our international audience? “We should…
Canada Sylvie Pilon, VP and GM at Lundbeck Canada, shares the highlights of her first year leading the Canadian affiliate; the challenges associated with Canada’s complex market access environment, particularly for mental illnesses; Lundbeck’s commitment to supporting patient associations in order to reduce the stigma associated with mental health conditions; and…
Brazil Marco Fireman, vice-minister and chairman of the National Commission for the Incorporation of Technologies (CONITEC); a board that advises the Brazilian Ministry of Health on the inclusion of new health technologies in the public healthcare scheme, discusses the crucial role of civic participation in public consultations, and documents the numerous…
Poland Marcin Czech, deputy minister and undersecretary of state at the Polish Ministry of Health, provides an in-depth perspective on Poland’s drug policy framework and the new medicines policy that aims to integrate pharmacoecomonics to ensure Poland can find an efficient balance between innovative and generic treatments for long-term stability. Furthermore,…
Bulgaria Peter Velev, chairman and CEO at Ecopharm, gives an update of the success of his generics company, Ecopharm, and introduces its new digital platform, Credoweb, created to accompany the pharmaceutical industry in the new era of digitalization. Before introducing Credoweb to our international audience, can you present yourself as well…
Canada Éric Gervais, executive vice-president of Duchesnay Inc, a privately-held, specialty Canadian pharma company focusing on women’s health, charts the company’s successful growth over the past 25 years, the innovative portfolio of in-house and in-licensed products they offer, as well as their plans for international expansion. Eric, you were Duchesnay’s first…
Canada Dr. Roman Szumski, vice-president of life sciences at the National Research Council (NRC), Canada’s industrial innovation and research organization, highlights the strategic and operational changes that have occurred over the past decade, NRC’s focus on promoting biologics and vaccines development within Canada’s life sciences environment, and NRC’s work in promoting…
Brazil Samuel Mauricio, vice-president for Brazil at Octapharma, one of the largest human protein manufacturers in the world, provides an insightful analysis of the Brazilian plasma market, demonstrating Octapharma’s remarkable willingness to further position itself as the partner of choice for the country’s public healthcare system. As the head of the…
Ukraine Ukraine’s bold decision to outsource public procurement of medicines to international agencies to combat rampant corruption has been well received by the pharma MNCs operational in the country, but faces criticism from domestic players. “Healthcare procurement was widely considered as one of the areas most seriously altered by corruption” Tetiana…
Canada Newly appointed minister of health of Canada, The Honourable Ginette Petitpas Taylor, shares the core tenets of her mandate, the Federal government’s priorities for investment into the Canadian healthcare ecosystem, as well as the strategic significance of the life sciences industry for the country. Healthcare was a core issue on…
See our Cookie Privacy Policy Here